Lvp Gp Iii, Llc - Net Worth and Insider Trading
Lvp Gp Iii, Llc Net Worth
The estimated net worth of Lvp Gp Iii, Llc is at least $37,420 dollars as of 2025-04-28. Lvp Gp Iii, Llc is the 10% Owner of Evoke Pharma Inc and owns about 14,504 shares of Evoke Pharma Inc (EVOK) stock worth over $37,420. Details can be seen in Lvp Gp Iii, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lvp Gp Iii, Llc has not made any transactions after 2018-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lvp Gp Iii, Llc
Lvp Gp Iii, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lvp Gp Iii, Llc owns 2 companies in total, including Evoke Pharma Inc (EVOK) , and OncoMed Pharmaceuticals Inc (OMED) .
Click here to see the complete history of Lvp Gp Iii, Llc’s form 4 insider trades.
Insider Ownership Summary of Lvp Gp Iii, Llc
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| EVOK | Evoke Pharma Inc | 2018-08-20 | 10 percent owner |
| OMED | OncoMed Pharmaceuticals Inc | 2013-07-23 | 10 percent owner |
Lvp Gp Iii, Llc Latest Holdings Summary
Lvp Gp Iii, Llc currently owns a total of 1 stock. Lvp Gp Iii, Llc owns 14,504 shares of Evoke Pharma Inc (EVOK) as of August 20, 2018, with a value of $37,420.
Latest Holdings of Lvp Gp Iii, Llc
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EVOK | Evoke Pharma Inc | 2018-08-20 | 14,504 | 2.58 | 37,420 |
Holding Weightings of Lvp Gp Iii, Llc
Lvp Gp Iii, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Lvp Gp Iii, Llc has made a total of 0 transactions in Evoke Pharma Inc (EVOK) over the past 5 years. The most-recent trade in Evoke Pharma Inc is the acquisition of 3,472 shares on August 20, 2018, which cost Lvp Gp Iii, Llc around $1 Million.
Insider Trading History of Lvp Gp Iii, Llc
- 1
Lvp Gp Iii, Llc Trading Performance
GuruFocus tracks the stock performance after each of Lvp Gp Iii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lvp Gp Iii, Llc is 1.68%. GuruFocus also compares Lvp Gp Iii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lvp Gp Iii, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lvp Gp Iii, Llc's insider trading performs compared to the benchmark.
Performance of Lvp Gp Iii, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 32.77 | | | | | |
| Relative Return to S&P 500(%) | 30.19 | | | | | |
Lvp Gp Iii, Llc Ownership Network
Ownership Network List of Lvp Gp Iii, Llc
Ownership Network Relation of Lvp Gp Iii, Llc
Lvp Gp Iii, Llc Owned Company Details
What does Evoke Pharma Inc do?
Who are the key executives at Evoke Pharma Inc?
Lvp Gp Iii, Llc is the 10 percent owner of Evoke Pharma Inc. Other key executives at Evoke Pharma Inc include director & President and CEO David A Gonyer , Exec VP & Chief Bus. Officer Matthew J D'onofrio , and director & 10 percent owner Kenneth J Widder .
Evoke Pharma Inc (EVOK) Insider Trades Summary
Over the past 18 months, Lvp Gp Iii, Llc made no insider transaction in Evoke Pharma Inc (EVOK). Other recent insider transactions involving Evoke Pharma Inc (EVOK) include a net sale of 41 shares made by Nantahala Capital Management, Llc ,
In summary, during the past 3 months, insiders sold 0 shares of Evoke Pharma Inc (EVOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 41 shares of Evoke Pharma Inc (EVOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 41 shares.
Evoke Pharma Inc (EVOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Evoke Pharma Inc Insider Transactions
Lvp Gp Iii, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Lvp Gp Iii, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Lvp Gp Iii, Llc's mailing address is: San Francisco Ca 94111.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
